ACET Adicet Bio, Inc.
Healthcare$8.33+0.36%ClosedMarket Cap: $77.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.64
P/S
0.00
EV/EBITDA
-0.53
DCF Value
$2.93
FCF Yield
-118.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-80.4%
ROA
-64.3%
ROIC
-73.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-21.6M | $-20.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-31.9M | $-30.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-122.1M | $-116.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-28.0M | $-26.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-32.4M | $-31.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-29.9M | $-28.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-30.7M | $-28.7M | $— | — |
| FY null | $0.00 | NaN% | $-127.6M | $-117.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-33.2M | $-30.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-32.8M | $-29.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-30.9M | $-28.0M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-31.6M | $-29.5M | $-11.04 | — |